TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013
TCL Archive NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money. June 27, 2008
TCL Archive Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum January 8, 1993